Literature DB >> 20937176

Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis.

H-B Xu1, R-H Jiang, L Li, W Sha, H-P Xiao.   

Abstract

OBJECTIVE: To determine the accuracy of adenosine deaminase (ADA) measurements in the diagnosis of tuberculous meningitis (TBM).
DESIGN: After a systematic review of English language studies, the sensitivity, specificity and accuracy of ADA concentrations in the diagnosis of cerebrospinal fluid (CSF) were evaluated using random effects models. Summary receiver operating characteristic curves were used to summarise overall test performance.
RESULTS: Ten studies met our inclusion criteria. The sensitivity of ADA in the diagnosis of TBM was 0.79 (95%CI 0.75-0.83), specificity 0.91 (95%CI 0.89-0.93), positive likelihood ratio 6.85 (95%CI 4.11-11.41), negative likelihood ratio 0.29 (95%CI 0.19-0.44) and diagnostic odds ratio 26.93 (95%CI 12.73-56.97).
CONCLUSION: Our data suggest that ADA in the CSF can be a sensitive and specific target and a critical criteria for the diagnosis of TBM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937176

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  20 in total

Review 1.  Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis.

Authors:  L L Flores; K R Steingart; N Dendukuri; I Schiller; J Minion; M Pai; A Ramsay; M Henry; S Laal
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  Characteristics and biomarkers of patients with central nervous system infection admitted to a referral hospital in Northern Vietnam.

Authors:  Cuong Chi Ngo; Shungo Katoh; Futoshi Hasebe; Bhim Gopal Dhoubhadel; Tomoko Hiraoka; Sugihiro Hamaguchi; Anh Thi Kim Le; Anh Thi Hien Nguyen; Anh Duc Dang; Chris Smith; Lay-Myint Yoshida; Cuong Duy Do; Thuy Thi Thanh Pham; Koya Ariyoshi
Journal:  Trop Med Health       Date:  2021-05-21

Review 3.  Methods of rapid diagnosis for the etiology of meningitis in adults.

Authors:  Nathan C Bahr; David R Boulware
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

4.  Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis.

Authors:  Jorge Parra-Ruiz; V Ramos; C Dueñas; N M Coronado-Álvarez; R Cabo-Magadán; V Portillo-Tuñón; D Vinuesa; L Muñoz-Medina; J Hernández-Quero
Journal:  Infection       Date:  2015-04-14       Impact factor: 3.553

5.  Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis.

Authors:  Nathan C Bahr; Graeme Meintjes; David R Boulware
Journal:  J Med Microbiol       Date:  2019-04-17       Impact factor: 2.472

6.  Tuberculous meningitis: treat upon suspicion.

Authors:  Myrthe Elisabeth Sonneveld; S M Zinkstok; F J B Nellen; Adriaan G Holleboom
Journal:  BMJ Case Rep       Date:  2012-08-18

7.  The dubious value of cerebrospinal fluid adenosine deaminase measurement for the diagnosis of tuberculous meningitis.

Authors:  Pieter Ekermans; Adriano Dusé; Jaya George
Journal:  BMC Infect Dis       Date:  2017-01-31       Impact factor: 3.090

Review 8.  Body Fluid Interferon-γ Release Assay for Diagnosis of Extrapulmonary Tuberculosis in Adults: A Systematic Review and Meta-Analysis.

Authors:  Xiao-Xia Zhou; Ya-Lan Liu; Kan Zhai; Huan-Zhong Shi; Zhao-Hui Tong
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

Review 9.  Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.

Authors:  Surendra K Sharma; Alladi Mohan
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

10.  Clinical features, Outcomes and Molecular Profiles of Drug Resistance in Tuberculous Meningitis in non-HIV Patients.

Authors:  Jingya Zhang; Xuejiao Hu; Xin Hu; Yuanxin Ye; Mengqiao Shang; Yunfei An; Haimei Gou; Zhenzhen Zhao; Wu Peng; Xingbo Song; Yanhong Zhou; Mei Kang; Yi Xie; Xuerong Chen; Xiaojun Lu; Binwu Ying; Lanlan Wang
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.